The Invesco Small Cap Value Fund outperformed its benchmark in Q4 2025, driven by strong technology stock selection. Read the ...
The Invesco Value Opportunities Fund outperformed its benchmark in Q4 2025, driven by stock selection in IT and materials. Read the full analysis for more details.
Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar” or the “Company”), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results